Amanullah Kaleem

Amanullah Kaleem

Active Director Director DIN 08134613
DIN 08134613 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Amanullah Kaleem

Data last updated:

Amanullah Kaleem is a Director at Carolus Pharmaceuticals Private Limited (since 2018). The company operates in Pharma. Carolus Pharmaceuticals Private Limited reported revenue of ₹5.8 Lakh (FY 2024).

DIN 08134613
Primary Designation Director
Industry Pharma
First Appointment 16 May 2018
Oldest Company Age 8 yrs
Largest company Carolus Pharmaceuticals Private Limited · ₹5.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 May 20182018₹5.8 Lakh (FY 2024)Active

Board colleagues of Amanullah Kaleem

Directorship timeline

Open interactive timeline →
Carolus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amanullah Kaleem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amanullah Kaleem

Amanullah Kaleem currently holds 1 directorship: Carolus Pharmaceuticals Private Limited (Director, since 16 May 2018, revenue ₹5.8 Lakh (FY 2024)).

Amanullah Kaleem was first appointed on 16 May 2018 as Director at Carolus Pharmaceuticals Private Limited.

The current boards of Amanullah Kaleem's companies include Mohd Shamsad Ahmad (Carolus Pharmaceuticals Private Limited), Sheikh Wasiullah Kalim (Carolus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available